Asia Pacific Neurovascular Catheters Market

Asia Pacific Neurovascular Catheters Market Size, Share & Industry Trends Analysis Report By Type, By End-Use (Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers), By Application, By Country and Growth Forecast, 2023 - 2029

Report Id: KBV-15137 Publication Date: April-2023 Number of Pages: 101
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Asia Pacific Neurovascular Catheters Market would witness market growth of 7.3% CAGR during the forecast period (2023-2029).

Minimally invasive surgeries have become increasingly popular due to their ability to minimize risk and trauma compared to traditional surgical procedures. Hemorrhages, commonly known as strokes, occur due to impaired, obstructed, or wounded blood vessels that can lead to cerebral bleeding or circulation issues. Minimally invasive surgical methods are utilized in the treatment of cerebral blood vessel blockages. Minimally invasive endovascular surgery techniques are the preferred method for removing brain blockages in the field of business.

Minimally invasive techniques utilizing neurovascular catheters and other advanced devices are the preferred method for treating stroke, aneurysm, and other blood vessel conditions in the brain. This innovative technique provides a faster recovery time and reduces physical strain on the body in comparison to traditional open surgery.

In addition, minimally invasive neurovascular surgeries result in fewer disruptions to musculoskeletal structures, thereby enhancing the procedure's efficiency and reducing patient discomfort. The catheters offer various benefits, such as minimal invasion, easy access to intracranial space, and simplifying complex procedures due to advanced designs and features. These benefits make wound closure easier and enable faster healing compared to traditional open surgery.

The rising prevalence of neurological disorders due to the ageing population is becoming a significant concern for the sustainability of healthcare systems globally, particularly in low and middle-income countries. India is likely to experience a rise in the prevalence of neurological disorders owing to the swift epidemiological and demographic transition underway in the country. The percentage of non-communicable neurological disorders in India's total DALYs has increased from 4.0% in 1990 to 8.2% in 2019. The growing prevalence of neurological diseases is expected to increase the demand for neurovascular catheters for the treatment of such diseases. Moreover, the rising R&D and the advancement of these catheters are expected to increase their adoption further, boosting the market growth in the region.

The China market dominated the Asia Pacific Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $339 million by 2029. The Japan market is estimated to grow at a CAGR of 6.6% during (2023 - 2029). Additionally, The India market would register a CAGR of 7.9% during (2023 - 2029).

Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Neurovascular Catheters Market is Projected to reach USD 4.6 Billion by 2029, at a CAGR of 6.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Embolization Catheters
  • Access Catheters
  • Balloon Catheters
  • Microcatheters
  • Others

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Application

  • Brain Aneurysm
  • Embolic Stroke
  • Arteriovenous Malformations
  • Hydrolysate

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Stryker Corporation
  • Terumo Corporation
  • Integer Holdings Corporation
  • Penumbra, Inc.
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • Integra LifeSciences Corporation
  • Acandis GmbH
  • Spiegelberg GmbH & Co. KG
  • RAUMEDIC AG (REHAU Industries SE & Co. KG)
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo